New York punishes people for being White when it comes to COVID-19 testing and treatment

Authorities in New York are prioritizing non-White people for critical Wuhan coronavirus (COVID-19) treatments that are in short supply. This is according to leaked documents from the state’s Department of Health and Mental Hygiene (DHMH).

A document released by the department shows that eligibility for these treatments, including monoclonal antibody therapy and the administering of antiviral drugs like molnupiravir, requires candidates to have “a medical condition or other factors that increase their risk for severe illness.” (Related: Now New York is refusing monoclonal antibodies for white people.)

A bullet point below this criterion indicates that people who are non-White or are of Hispanic or Latino heritage should be considered as having a risk factor for severe illness, and therefore meets the DHMH’s standards to be prioritized for treatment.

“Non-White race or Hispanic/Latino ethnicity should be considered a risk factor, as longstanding systemic health and social inequities have contributed to an increased risk of severe illness and death from COVID-19,” read DHMH’s document.

Erin Silk, a spokeswoman for the state health department, claimed that being White does not disqualify an individual from receiving treatment. She claimed that the state’s prioritization guidelines “comes directly from the CDC.”

“Systemic poverty, which has clearly proven to be a risk factor in populations in New York State and nationwide, is added to the algorithm of prioritization similar to all other risk factors,” said Silk. “It is merely mentioned as a factor that increases risk.”

Despite Silk’s claims, it appears very clear that White New Yorkers are at a disadvantage compared to New Yorkers of other races and ethnicities as a result of the DHMH’s new policy regarding the prioritization of treatment. No special risk factors have been attributed to White people that would give them any kind of priority for COVID-19 treatments.

Other eligibility requirements for prioritization include a person being at least 12 years old, weighing at least 88 pounds for receiving nirmatrelvir/ritonavir, or being at least 18 years old for receiving molnupiravir. The person must also only have mild to moderate COVID-19 symptoms and must be able to start treatment within five days of symptom onset.

New York City authorities also discriminating against White patients

In a conversation with representatives from New York City’s Department of Health and Mental Hygiene (NYC Health), the office of city councilman Joe Borelli said his constituents in Staten Island’s South Shore region were experiencing difficulties getting tested for COVID-19 at city facilities.

“Our office has been receiving calls regarding the mobile NYC H+H testing sites such as Wolfes Pond Park,” wrote Briana Nasti, a staffer at Borelli’s office, in a Dec. 22 email. “It appears many are waiting with delays, and are being turned away after waiting for hours.”

NYC Health later informed Nasti that the agency was prioritizing neighborhoods flagged by the city’s Taskforce on Racial Inclusion & Equity.

This task force was created during the tenure of former Mayor Bill de Blasio. It identified 13 underserved neighborhoods in the city that will receive “priority” attention during the distribution of city services, such as COVID-19 testing.

The 13 neighborhoods were picked based on NYC Health’s analysis of “health status, living conditions, social inequities, occupation and COVID-19 Wave 1 Impact.” NYC Health has never disclosed its methodology.

This means that predominantly White neighborhoods like South Shore will not receive crucial city services like COVID-19 testing programs until the 13 supposedly underserved and more racially diverse neighborhoods are provided with services first.

The population of South Shore is predominantly White, as is the rest of Staten Island. Despite having one of the highest COVID-19 rates in the city in December, not one of the borough’s many neighborhoods received priority status. For an island with a population of around half a million, the borough only has 13 city testing sites, all of which can be found in the more diverse North Shore area.

“I think we are clearly not on their racial and ethnic rubric priority list,” said Borelli. “There was no problem pointing fingers at the South Shore of Staten Island when it came to sending [COVID-19 mandate] enforcement goons.”

Councilman Robert Holden from Queens said his district still does not have a city COVID-19 testing site.

“COVID-19 does not discriminate by politics … We need testing sites and home test kits immediately,” said Holden. He claimed city officials see “districts of middle-class taxpayers who didn’t vote for him as people who don’t deserve protection from COVID-19.”

Listen to this Situation Update episode of the “Health Ranger Report,” a podcast by Mike Adams, the Health Ranger, as he talks about how hospitals are refusing to provide White people with COVID-19 treatments.

This video is from the Health Ranger Report channel on Brighteon.com.

Learn more about how authorities are passing anti-White policies by reading the latest articles at RaceWar.news.

Sources include:

LifeSiteNews.com

Gazette.com

FoxNews.com

NYPost.com